Balili, Monica G.
HRN: 24-97-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2024
CO-AMOXICLAV 625MG (TAB)
05/05/2024
05/11/2024
PO
625 Mg Tab
BID
Sp Nsvd, Repair Of Second Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes